Burning Rock Biotech (BNR) Competitors $6.58 +0.43 (+6.99%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BNR vs. SERA, PSNL, LFMD, BDSX, QIPT, EUDA, XGN, PIII, ENZ, and CCMShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Sera Prognostics (SERA), Personalis (PSNL), LifeMD (LFMD), Biodesix (BDSX), Quipt Home Medical (QIPT), EUDA Health (EUDA), Exagen (XGN), P3 Health Partners (PIII), Enzo Biochem (ENZ), and Concord Medical Services (CCM). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Sera Prognostics Personalis LifeMD Biodesix Quipt Home Medical EUDA Health Exagen P3 Health Partners Enzo Biochem Concord Medical Services Sera Prognostics (NASDAQ:SERA) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation. Do institutionals & insiders have more ownership in SERA or BNR? 54.6% of Sera Prognostics shares are held by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are held by institutional investors. 15.8% of Sera Prognostics shares are held by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, SERA or BNR? Sera Prognostics has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Do analysts recommend SERA or BNR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sera Prognostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SERA or BNR more profitable? Sera Prognostics has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -83.50%. Sera Prognostics' return on equity of -51.73% beat Burning Rock Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Sera PrognosticsN/A -51.73% -36.94% Burning Rock Biotech -83.50%-60.68%-42.30% Does the MarketBeat Community prefer SERA or BNR? Sera Prognostics received 5 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 38.46% of users gave Sera Prognostics an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote. CompanyUnderperformOutperformSera PrognosticsOutperform Votes1038.46% Underperform Votes1661.54% Burning Rock BiotechOutperform Votes531.25% Underperform Votes1168.75% Which has stronger valuation & earnings, SERA or BNR? Sera Prognostics has higher earnings, but lower revenue than Burning Rock Biotech. Sera Prognostics is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSera Prognostics$94K3,154.45-$36.24M-$0.99-8.87Burning Rock Biotech$510.89M0.13-$92.07M-$3.00-2.19 Does the media refer more to SERA or BNR? In the previous week, Sera Prognostics and Sera Prognostics both had 1 articles in the media. Burning Rock Biotech's average media sentiment score of 1.90 beat Sera Prognostics' score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sera Prognostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Burning Rock Biotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummarySera Prognostics beats Burning Rock Biotech on 12 of the 16 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ ExchangeMarket Cap$67.41M$2.93B$7.15B$9.07BDividend YieldN/A15.63%2.33%4.22%P/E Ratio-2.1916.0228.2017.19Price / Sales0.13284.46403.34116.80Price / CashN/A472.1131.0037.86Price / Book0.625.195.814.78Net Income-$92.07M-$32.86M$125.99M$225.60M7 Day Performance-2.23%-3.01%4.01%-1.23%1 Month Performance22.30%2.96%8.75%3.37%1 Year Performance-11.08%12.37%19.17%16.58% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech1.9789 of 5 stars$6.58+7.0%N/A-12.3%$67.41M$510.89M-2.191,390Positive NewsGap DownSERASera Prognostics0.2225 of 5 stars$8.42-2.3%N/A+28.2%$284.34M$310,000.00-8.71120News CoveragePositive NewsPSNLPersonalis3.9707 of 5 stars$3.81-0.3%$6.81+78.8%+293.8%$269.18M$73.48M-2.27400Analyst ForecastNews CoverageGap UpLFMDLifeMD1.4002 of 5 stars$5.77+1.4%$11.57+100.5%-37.0%$249.91M$193.06M-8.89230Positive NewsBDSXBiodesix2.5565 of 5 stars$1.33-0.7%$3.06+130.1%-4.8%$193.49M$65.56M-3.44220QIPTQuipt Home Medical2.5521 of 5 stars$3.09+2.7%$6.25+102.3%-49.5%$133.15M$221.74M-27.361,200Earnings ReportAnalyst RevisionNews CoveragePositive NewsGap UpEUDAEUDA Health0.3187 of 5 stars$5.38-9.7%N/A+246.2%$132.50M$3.81M0.002XGNExagen4.6636 of 5 stars$6.01+4.0%$7.00+16.5%+191.0%$106.02M$52.55M-6.14220Gap UpHigh Trading VolumePIIIP3 Health Partners2.3841 of 5 stars$0.19-5.2%$2.38+1,122.3%-83.0%$69.72M$1.48B-0.24500News CoverageENZEnzo Biochem0.7773 of 5 stars$1.02flatN/A-46.7%$53.29M$31.91M0.00520Earnings ReportAnalyst ForecastCCMConcord Medical Services0.3768 of 5 stars$4.99+0.8%N/A-58.8%$21.67M$471.70M0.00970Analyst ForecastNews CoverageGap Down Related Companies and Tools Related Companies Sera Prognostics Competitors Personalis Competitors LifeMD Competitors Biodesix Competitors Quipt Home Medical Competitors EUDA Health Competitors Exagen Competitors P3 Health Partners Competitors Enzo Biochem Competitors Concord Medical Services Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BNR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
